Active Studies

Build 3 - Effects of bosentan on survival and prevention of disease worsening in patients with Idiopathic Pulmonary Fibrosis

PIPF012 - An Open-Label Extension Study of the Long-Term Safety of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis (IPF) Who Complete the CAPACITY Studies

STEP-IPF - Sildenafil Trial of Exercise Performance in Idiopathic Pulmonary Fibrosis

DYSPNEA - Understanding Dyspnea in Patients with Interstitial Lung Disease

ARTEMIS-IPF - A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Parallel-Group, Event-Driven Study to Evaluate the Efficacy and Safety of Ambrisentan in Subjects with Early Idiopathic Pulmonary Fibrosis (IPF)

Future Studies

ARTEMIS-PH - A Phase 3, Randomized, Double Blind, Placebo Controlled, Multi Center, Parallel Group Study to Evaluate the Efficacy and Safety of Ambrisentan in Subjects with Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension

MUSIC - A double-blind, randomized, placebo-controlled, multicenter, parallel group study to evaluate the efficacy, safety, and tolerability of macitentan in patients with idiopathic pulmonary fibrosis

PANTHER-IPF - Prednisone, Azathioprine, N-acetylcysteine: A Study That Evaluates Response in Idiopathic Pulmonary Fibrosis. A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Study

SLSII - Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease.